IGI Logo
Toggle Navigation
News
Hindi
Hindi News
Top News
Screeners
Stocks
Stocks Screener
Stock
News
Stock Market Home Page
Stock News
Industry News
Economy News
Stock on the move
Expert Views
Research Reports
Company Result
Comp Info And Fundamentals
Company Profile
Equity
Financial Ratios
Results
Balance Sheet
Profit And Loss
Cash Flow
Share Holding
Derivatives (F&O)
Get Quotes
Market Watch
Top Gainers
Top Losers
Top Traded Quantity
Top Traded Value
Most Active Puts
Derivatives (F&O)
Most Active Calls
Put Call Ratio
Highest In Premium
Daily Settlement Price
FII and DII Statistics
Open Interest: Highest In OI
Open Interest: Lowest In OI
Derivatives (F&O)
Open Interest: Increase in OI Increase in Price
Open Interest: Decline in OI Decrease in Price
Derivative Watch
Derivatives Dashboard
Historical Data
List of Underlyings & Underlying Info
Derivative Watch
Derivatives Dashboard
Market Reports
Top Gainers
Top Losers
Monthly High/Low
52 Week High
52 Week Low
Market Cap Gainers
Market Cap Losers
PE Ratio
>More Market Reports
IPO
News
IPO News
IPO Issue Reports
Commodity
Commodity Market
Commodity Home Page
Commodity News
Commodity Reports
Market Details
Get Quotes
Top Gainers
Top Losers
Top Volume
Top Value
Top Gainers Spot Market
Top Losers Spot Market
High & Low
Commodity Indices
Technical Analysis
Advance Declines
High & Low
Highest In OI
Lowest OI
Increase In Open Interest(%)
Descrease In Open Interest(%)
Currency
News
Currency News
Economy News
Currency Reports
Mutual Fund
News
Mutual Fund Home Page
Mutual Fund News
Mutual Fund Details
Mutual Fund Home Page
Compare Scheme
Scheme Profile
Mutual fund Investment
Mutual Fund Share Holding
Mutual Fund Statistics
Mutual fund Gainers
Mutual fund Losers
Biggest Schemes
Best Performers
Latest Dividend Details
Tools
Multi Scheme Comparison Tool
Dividend Details
Performance Map
Mutual fund Investment
Mutual fund Share Holding
Mutual Fund Search Category Rankings
Widgets
Stock Widgets
Watchlist
Heatmap
Mutual Fund Widgets
Watchlist
Calculators
EMI Calculator
SIP Calculator
SWP Calculator
GST Calculator
FD Calculator
RD Calculator
Wealth
World
Tips
Intraday Tips
Market Outlook
Stock Tips
Commodity Tips
Currency Tips
Reports
Short Term Investment Opportunities
Long Term Investment Opportunities
Sector Analysis
Commodity Reports
Currency Reports
Mutual Fund Analysis
Podcast
Videos
Videos Category
Business Videos
Budget Videos
News And Politics
Entertainment Videos
Sports Videos
Lifestyle And Fashion Videos
Global News Videos
Calculators
EMI Calculator
SIP Calculator
SWP Calculator
GST Calculator
FD Calculator
RD Calculator
More
Budget 2024
Astrology
Women
Politics
Entertainment
Car&Bike
Gadgets
Lifestyle
Sports
Health
Fashion
Diwali Reports
Diwali Expert Reports
News
Astrology
Beyond Market Car
Beyond Market Entertainment
Beyond Market Fashion
Beyond Market Gadgets
Beyond Market Health
Beyond Market India
Beyond Market Life Style
Beyond Market Sports
Broking Firm Views
Broking Firm Views - Long Term Report
Broking Firm Views - Sector Report
Broking Firm Views - Short Term Report
Budget 2024 Sector Reports
Budget Bites
Budget Economic Servey
Budget Expert Views
Budget Industry
Budget News
Budget Wishlist
Commodities
Commodities Reports
Commodity Top News
Company News
Company Result
Currency News
Currency Report
Currency Top News
Diwali Expert Views
Diwali Market Outlook
Diwali Report
Diwali Technical Report
Economy News
Expert View Institution
Expert Views
Industry News
IPO Analysis
IPO More News
IPO Reports
IPO Top News
Market Outlook
Mutual Fund Analysis
Mutual Fund Expert Views
Mutual Fund More News
Mutual Fund Top News
Podcast - Market Ki Awaaz
Special Event Expert Views
Special Event Reports
Startup
Startup Expections
Startup Speak
Stock Market
Stock On The Move
Top News
Top Stories
Videos
Videos Business
Videos Entertainment
Videos Global News
Videos Lifestyle And Fashion
Videos News And Politics
Videos Sports
Wealth
Women
World Market More News
World Top News
Search
In-line 2Q; Future growth drivers intact Aurobindo’s (ARBP) 2QFY25 results were broadly in-line with our expectations. Revenue/EBITDA/PAT grew 8%/12%/8% YoY, and margins expanded by 65 bps YoY. The US segment, which accounts for 45% of sales, grew by 4% YoY, marred by supply chain challenges – this should ease as production gets streamlined. Europe reported robust 19% YoY grow driven by strong performance across key markets. Growth markets grew 44% YoY and API segments reported...
Buy Aurobindo Pharma Ltd For Target Rs.1,755 By JM Financial Services
Aurobindo Pharma is currently trading at Rs. 1452.90, up by 14.35 points or 1.00% from its previous closing of Rs. 1438.55 on the BSE. The scrip opened at Rs. 1438.55 and has touched a high and low of Rs. 1459.75 and Rs. 1425.05 respectively. So far 20028 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1592.55 on 13-Sep-2024 and a 52 week low of Rs. 834.90 on 01-Nov-2023. Last one week high and low of the scrip ...
Aurobindo Pharma rises on getting USFDA`s final approval for Cephalexin Tablets
Federal Bank Ltd Buy Federal Bank Ltd @ 195.50-196.50 Target 198.60 Stop Loss 194.50 Aurobindo Pharma Ltd Sell Aurobindo Pharma Ltd @ 1475-1478 Target 1460.00 Stop Loss 1486.50 Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Federal Bank Ltd and Aurobindo Pharma Ltd By ICICI Direct
Operationally in-line quarter; broad-based growth across segments Efforts under way to resolve regulatory issue/scale up Pen-G production Aurobindo Pharma (ARBP) delivered in-line operational performance in 1QFY25. The robust execution across key markets was partly offset by seasonality and higher remediation costs for the quarter. * We largely maintain our estimates for FY25/FY26. We value ARBP at 18x 12M forward earnings to arrive at our TP of INR1,500. * ARBP is progressing wel...
Neutral Aurobindo Pharma Ltd For Target Rs. 1,500 By Motilal Oswal Financial Services Ltd
Aurobindo Pharma is currently trading at Rs. 1517.20, up by 14.90 points or 0.99% from its previous closing of Rs. 1502.30 on the BSE. The scrip opened at Rs. 1502.30 and has touched a high and low of Rs. 1536.35 and Rs. 1490.90 respectively. So far 13362 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1,536.35 on 19-Aug-2024 and a 52 week low of Rs. 815.15 on 05-Sep-2023. Last one week high and low of the scrip...
Aurobindo Pharma rises on eyeing production commencement in China facility
Aurobindo Pharma is currently trading at Rs. 1453.50, up by 6.35 points or 0.44% from its previous closing of Rs. 1447.15 on the BSE. The scrip opened at Rs. 1458.80 and has touched a high and low of Rs. 1487.65 and Rs. 1443.00 respectively. So far 35153 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1497.65 on 09-Aug-2024 and a 52 week low of Rs. 815.15 on 05-Sep-2023. Last one week high and low of the scrip s...
Aurobindo Pharma gains on reporting strong Q1 numbers; consolidated net profit surges 61%
Aurobindo Pharma is currently trading at Rs. 1479.40, up by 15.30 points or 1.05% from its previous closing of Rs. 1464.10 on the BSE. The scrip opened at Rs. 1477.75 and has touched a high and low of Rs. 1480.40 and Rs. 1448.85 respectively. So far 8770 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1480.40 on 08-Aug-2024 and a 52 week low of Rs. 815.15 on 05-Sep-2023. Last one week high and low of the scrip s...
Aurobindo Pharma surges on securing USFDA’s approval for Estradiol Vaginal Inserts
Larsen&Toubro Ltd Buy Larsen&Toubro Ltd. @ 3478-3482 Target 3518.00 Stop Loss 3459.80 Aurobindo Pharma Ltd Buy Aurobindo Pharma Ltd. @ 1249-1252 Target 1268.00 Stop Loss 1241.80 Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Larsen&Toubro Ltd And Aurobindo Pharma Ltd By ICICI Direct
Aurobindo Pharma is currently trading at Rs. 1214.65, up by 19.00 points or 1.59% from its previous closing of Rs. 1195.65 on the BSE. The scrip opened at Rs. 1217.85 and has touched a high and low of Rs. 1225.00 and Rs. 1208.40 respectively. So far 12735 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1245.60 on 24-May-2024 and a 52 week low of Rs. 584.55 on 29-May-2023. Last one week high and low of the scrip ...
Aurobindo Pharma soars on reporting 79% rise in Q4 consolidated net profit
Aurobindo Pharma is currently trading at Rs. 1145.20, up by 16.55 points or 1.47% from its previous closing of Rs. 1128.65 on the BSE. The scrip opened at Rs. 1126.40 and has touched a high and low of Rs. 1146.95 and Rs. 1118.60 respectively. So far 6564 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1177.00 on 30-Jan-2024 and a 52 week low of Rs. 581.50 on 19-May-2023. Last one week high and low of the scrip s...
Aurobindo Pharma trades in green on BSE
Aurobindo Pharma is currently trading at Rs. 1168.50, up by 15.80 points or 1.37 % from its previous closing of Rs. 1152.70 on the BSE. The scrip opened at Rs. 1146.95 and has touched a high and low of Rs. 1168.90 and Rs. 1141.80 respectively. So far 19971 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1177.00 on 30-Jan-2024 and a 52 week low of Rs. 581.50 on 19-May-2023. Last one week high and low of the scrip...
Aurobindo Pharma trades higher on the BSE
Steel Authority of India Ltd Buy Steel Authority of India Ltd @149.50-150.00 Target 152.30 Stop Loss 148.20 Aurobindo Pharma Ltd Buy Aurobindo Pharma Ltd @1130-1132 Target 1144.00 Stop Loss 1124.90 Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Steel Authority of India Ltd And Aurobindo Pharma Ltd By ICICI Direct
cGMP cloud over good results Q3FY24 beats expectations Aurobindo Pharma (ARBP IN) beat our revenue and EBITDA estimates by 2% and 9% in Q3FY24. Revenue across business segments came broadly in line with our expectations. Lower other expenses helped EBITDA margin come in 150bps above our estimate, leading to an EBITDA beat. We estimate ~USD 40mn contribution from high-margin gRevlimid in Q3FY24. ARBP Aurobindo management in...
Buy Aurobindo Pharma Ltd. For Target Rs.1208 By Elara Capital
Aurobindo Pharma Ltd * We are seeing decent traction in the Pharma space and AUROPHARMA is offering a fresh buying opportunity. * It has ended its long corrective phase, after registering a breakout from the bullish price pattern with noticeable volumes. * Following price action and buoyancy in the pharma space suggests price is set to test its previous swing high. * We thus recommend creating fresh longs in the mentioned range. Buy Aurobin...
Stock of the day : Aurobindo Pharma Ltd For Target Rs. 1150 - Religare Broking
Axis Bank Ltd Buy Axis Bank Ltd @1048-1050 Target 1061.00 Stop Loss 1042.80 Aurobindo pharma Ltd Buy Aurobindo pharma Ltd @1066-1068 Target 1079.30 Stop Loss 1061.80 Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Axis Bank Ltd And Aurobindo pharma Ltd By ICICI Direct
Aurobindo Pharma is currently trading at Rs. 1004.05, up by 14.65 points or 1.48% from its previous closing of Rs. 989.40 on the BSE. The scrip opened at Rs. 1006.45 and has touched a high and low of Rs. 1013.90 and Rs. 996.00 respectively. So far 8516 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1177.00 on 30-Jan-2024 and a 52 week low of Rs. 466.00 on 21-Mar-2023. Last one week high and low of the scrip sto...
Aurobindo Pharma rises on getting final nod to manufacture, market Mometasone Furoate Monohydrate Nasal Spray
Aurobindo Pharma is currently trading at Rs. 1097.35, up by 21.25 points or 1.97% from its previous closing of Rs. 1076.10 on the BSE. The scrip opened at Rs. 1077.50 and has touched a high and low of Rs. 1097.35 and Rs. 1072.00 respectively. So far 3359 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1177.00 on 30-Jan-2024 and a 52 week low of Rs. 443.15 on 14-Mar-2023. Last one week high and low of the scrip s...
Aurobindo Pharma rises on getting final nod to manufacture, market Fingolimod Capsules, 0.5 mg
Aurobindo Pharma is currently trading at Rs. 1030.20, up by 12.25 points or 1.20% from its previous closing of Rs. 1017.95 on the BSE. The scrip opened at Rs. 1030.20 and has touched a high and low of Rs. 1040.00 and Rs. 1019.00 respectively. So far 53230 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1177.00 on 30-Jan-2024 and a 52 week low of Rs. 443.15 on 14-Mar-2023. Last one week high and low of the scrip ...
Aurobindo Pharma rises on getting USFDA`s final nod for Deflazacort Tablets
Aurobindo Pharma is currently trading at Rs. 1012.95, up by 10.95 points or 1.09% from its previous closing of Rs. 1002.00 on the BSE. The scrip opened at Rs. 1038.75 and has touched a high and low of Rs. 1038.75 and Rs. 1000.20 respectively. So far 209328 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1177.00 on 30-Jan-2024 and a 52 week low of Rs. 443.15 on 14-Mar-2023. Last one week high and low of the scrip...
Aurobindo Pharma soars on reporting 91% rise in Q3 consolidated net profit
Oil and Natural Gas Corporation Ltd Buy Oil and Natural Gas Corporation Ltd @233-234; Target 236.50 ; Stop Loss 231.70 Aurobindo Pharma Ltd Buy Aurobindo Pharma Ltd @1124-1126; Target 1137.80 ; Stop Loss 1118.70 Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Oil and Natural Gas Corporation Ltd And Aurobindo Pharma Ltd By ICICI Direct
Titan(TITIND) Buy Titan Ltd @3752-3755; Target 3788.00; Stop Loss 3734.00 Aurobindo Pharma Buy Aurobindo Pharma Ltd @1142-1144; Target 1156; Stop Loss 1137.70 Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Titan Ltd And Aurobindo Pharma Ltd By ICICI Direct
Tata Consultancy Services Ltd Buy Tata Consultancy Services Ltd @3785-3788; Target 3825.00; Stop Loss 3769.00 Aurobindo Pharma Ltd Buy Aurobindo Pharma Ltd @1091-1093; Target 1104.00; Stop Loss 1085.80 Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Tata Consultancy Services Ltd And Aurobindo Pharma Ltd By ICICI Direct
Aurobindo Pharma Ltd Buy Aurobindo Pharma Ltd @1040-1042; Target 1052.00; Stop Loss 1036.70 Canara Bank Ltd Buy Canara Bank Ltd @402.50-403.50; Target 408.20; Stop Loss 399.70 Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Aurobindo Pharma Ltd And Canara Bank By ICICI Direct
Aurobindo Pharma is currently trading at Rs. 1051.50, up by 24.75 points or 2.41% from its previous closing of Rs. 1026.75 on the BSE. The scrip opened at Rs. 1030.15 and has touched a high and low of Rs. 1058.20 and Rs. 1021.55 respectively. So far 114330 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1058.20 on 22-Nov-2023 and a 52 week low of Rs. 397.30 on 03-Feb-2023. Last one week high and low of the scrip...
Aurobindo Pharma shines on incorporating wholly owned subsidiary
Larsen & Toubro Ltd Buy Larsen & Toubro Ltd @3072-3075; Target 3104.00; Stop Loss 3058.00 Aurobindo Pharma Ltd Buy Aurobindo Pharma Ltd @1027-1029; Target 1039.00; Stop Loss 1023.40 Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Larsen & Toubro Ltd And Aurobindo Pharma Ltd By ICICI Direct
India's Aurobindo Pharma Ltd reported a better-than-expected 84.9% rise in second-quarter profit on Thursday, driven by strong sales in core markets Europe and the United States amid stablising drug prices. Consolidated net profit attributable to owners of the holding company rose to 7.57 billion Indian rupees ($90.91 million) from 4.09 billion rupees a year earlier. Analysts on an average had expected a profit of 6.22 billion rupees, according to LSEG data. The Hyderabad-base...
India's Aurobindo Pharma posts jump in profit on strong overseas demand
HCL Technologies Limited Buy HCL Technologies Limited @1269-1272; Target 1285.20; Stop Loss 1265.40 Aurobindo Pharma Limited Buy Aurobindo Pharma Limited @851-852; Target 843.20; Stop Loss 856.80 Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : HCL Technologies Limited And Aurobindo Pharma Limited By ICICI Direct
Aurobindo Pharma is currently trading at Rs. 878.45, up by 12.25 points or 1.41% from its previous closing of Rs. 866.20 on the BSE.The scrip opened at Rs. 865.00 and has touched a high and low of Rs. 884.90 and Rs. 859.10 respectively. So far 131903 shares were traded on the counter.The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 930.00 on 29-Sep-2023 and a 52 week low of Rs. 397.30 on 03-Feb-2023.Last one week high and low of the scrip stood at Rs. 922.00 and R...
Aurobindo Pharma surges after its arm gets USFDA`s final nod for Testosterone Cypionate Injection
Tata Consultancy Services Ltd Buy Tata Consultancy Services Ltd @3480-3484; Target 3526.00; Stop Loss 3461.00Aurobindo Pharma Ltd
Stock Picks : Tata Consultancy Services Ltd And Aurobindo Pharma Ltd By ICICI Direct
Load More